Cancer is associated with a considerably increased risk of sepsis, especially in patients with haematological malignancies 1 because of immune suppression related to the disease itself or imposed by anticancer treatments. As a result, cancer patients now represent a significant proportion of admissions to the intensive care unit (ICU) for severe infections: 17% of medical admissions associated with severe sepsis in the USA 2 and 15.4% of septic shock patients in a French ICU cohort. 3 Whereas recent advances in the management of severe sepsis and septic shock only have led to a moderate decrease in mortality in general populations, the prognosis of cancer patients in septic shock has markedly improved over recent years. Thus, survival is now similar to the general population in experienced centres and approaches 50%. 4 Whatever the population studied, the number and the extent of organ failures are the main prognostic factors in ICU cancer patients, 5 and particularly in those presenting with septic shock. 6 Myocardial dysfunction in sepsis is now well described: impairment of systolic, diastolic, and right ventricle (RV) function are described. 7 -9 However, little data exist regarding the prognostic value of cardiac dysfunctions in septic shock cancer patients. The aim of this study was to assess the association between echocardiographic measures of cardiac function in cancer patients presenting with septic shock, and ICU mortality.
pressure ,60 mm Hg despite adequate volume resuscitation) requiring vasopressor therapy. 10 Exclusion criteria were: age younger than 18 yr; presence of moderate-to-severe valvular heart disease; echocardiographic evidence of regional ischaemia or previous infarction; or decision of therapeutic limitation taken before onset of septic shock. Patients with septic shock were systematically admitted to the ICU, once the diagnosis was made. They came from the haematology or oncology units. All patients received broad-spectrum antibiotic treatment (b-lactam plus an amino glycoside or a quinolone plus a glycopeptide) immediately after initial clinical evaluation. Besides antibiotics, all patients received standard supportive care for the shock according to standard recommendations. 10 Fluid expansion (using crystalloids or colloids) and the use of epinephrine, norepinephrine, and/or dobutamine were decided by the physician in charge of the patient. Haemodynamic evaluation, using echocardiography, was routinely performed in all patients. Both clinical (heart rate, arterial pressure, peripheral perfusion, urine output, central venous pressure, and saturation) and echocardiographic variables were considered in determining the requirement and response to fluid management. In particular, fluid administration was reduced if cardiac filling pressures increase (right ventricular dilatation, E/e ′ ratio .10, or both) without concurrent haemodynamic improvement. Stress-dose steroids were routinely administered in our patients presenting with septic shock. The study was approved by the Paoli-Calmettes Institute institutional review board which waived the need for informed consent.
Echocardiography
Transthoracic echocardiography and Doppler examination were performed by experienced physicians using a General electric Vivid-I machine as soon as possible within the first 48 h of septic shock diagnosis. All measurements were recorded over four consecutive cardiac cycles and at end-expiration for ventilated patients. Data from the first examination were collected and analysed by two echocardiography experts who were blinded to the treatment and outcome of patients; we averaged the values of both observers. Differences in interpretations were resolved by agreement. The following measurements were made using the standard parasternal and apical views: left ventricle (LV) end-diastolic volume and LV endsystolic volume using the biplane modified Simpson's rule from which LV ejection fraction (LVEF) was calculated; LV and RV end-diastolic areas from which the RV/LV ratio was calculated and LV outflow tract diameter. The peak mitral inflow E and A velocity waves on pulsed-Doppler, E/A ratio, and E-wave deceleration time were measured from the apical fourchamber view. Cardiac output and LV outflow tract velocitytime integral were measured from the apical five-chamber view. Using tissue-Doppler imaging at the lateral mitral annulus on the four-chamber view, the systolic s ′ , the diastolic e ′ , and a ′ peak velocity were measured and the LV filling index E/e ′ ratio and the Tei tissular index were calculated in accordance with the guidelines.
11 -14 Delta e ′ (theoretical e ′ 2measured e ′ ) was calculated using normative reference value for tissue Doppler imaging. 15 This parameter takes into account diastolic dysfunction related to age, and thus reflects non-physiological diastolic dysfunction. The peak systolic tricuspid insufficiency gradient and tricuspid annular plane systolic excursion were measured from the apical chamber view. As previously described, 16 
Clinical data and laboratory results
The following clinical data were collected during the ICU stay ( 
Statistical analysis
All data are presented as frequencies (%) for categorical variables and medians (25th -75th percentiles) for continuous variables. Echocardiographic parameters and characteristics of patients during ICU hospitalization were compared across the groups of ICU survivors and decedents by using Fisher's exact test and the Wilcoxon rank-sum test. We performed logistic regression analyses to identify variables that significantly influenced ICU mortality, as measured by the estimated odds ratio (OR) with the 95% confidence interval (CI). Variables yielding P-values of ,0.10 in the bivariate analyses were entered into a backward stepwise logistic regression model where ICU mortality was the outcome variable of interest. Lastly, we forced variables of clinical interest that may be suspected to be associated with outcome into the final model. Two models were thus constructed. In the first model ('echocardiographic model'), significant echocardiographic parameters were tested for the variable of interest. In the second model ('classical model'), usual clinical parameters, including those selected by the 'echocardiographic model', were also tested for the variable of interest. The Hosmer -Lemeshow test was used to check goodness-of-fit of the logistic regression.
To account for the competing risk of discharge alive, survival in ICU was presented by plotting one minus the cumulative incidence of death in ICU for both groups, and the cumulative incidence of death in ICU was compared between patients with and without diastolic dysfunction using the Gray test. All tests were two-sided, and P-values of ,0.05 were considered statistically significant. Analysis was performed using SPSS, version 16.0 software (SPSS, Inc., Chicago, IL, USA).
Results
Seventy-six patients were initially included in the present study. Echocardiographic measurements were not obtainable in four patients because of poor echocardiographic views. Two of these patients were receiving invasive MV at the time of assessment. Seventy-two cancer patients presenting with septic shock were studied: 47 (65.3%) patients presented with haematologic malignancies and 26 (36.1%) with solid tumours. Characteristics of patients are reported in 
Echocardiographic parameters and ICU mortality
Fifty-two (72%) patients were studied within 24 h of developing septic shock. Thirty (42%) patients were mechanically ventilated at the time of echocardiography examination [level of 
Myocardial dysfunction
Systolic dysfunction was observed in 39 (54%) patients, diastolic dysfunction in 33 (46%) patients, and RV dysfunction in 17 (24%) patients. Dividing the patients according to systolic and diastolic dysfunction yielded four subgroups: 21 (29.2%) patients without any dysfunction, 18 (25%) patients with isolated systolic dysfunction, 12 (16.7%) with isolated diastolic dysfunction, and 21 (29.2%) with both systolic and diastolic dysfunction. Table 2 Echocardiographic data and ICU mortality, univariate analysis. Data are expressed as number (%) or median (25th-75th percentiles). E, peak early diastolic transmitral flow velocity; A, peak active (late) diastolic transmitral flux velocity; E/A, ratio of E to A; DT, E-wave deceleration time; e ′ , peak early diastolic lateral mitral annulus velocity; a ′ , peak active (late) diastolic lateral mitral annulus velocity; s ′ , peak systolic lateral mitral annulus velocity; E/e ′ , ratio of E to e ′ ; LVEF, left ventricle ejection fraction; IT gradient, peak systolic tricuspid insufficiency gradient; TAPSE, tricuspid annular plane systolic excursion; RV dilatation, ratio of RV end-diastolic area to LV end-diastolic area .0.6; VTI, left ventricular outflow tract velocity-time integral . Delta e ′ which reflects non-physiological diastolic dysfunction was significantly higher in non-survivors (P,0.005) (Fig. 2) .
Overall predictors of in-ICU mortality
Among the 72 patients, 35 (49%) died in-ICU and 44 (64%) before day 90. Using univariate analysis, SOFA score at admission, need for RRT, use of invasive MV, and occurrence of diastolic dysfunction (e ′ ≤8 cm s 21 ) were associated with ICU mortality (Table 5) . Among these parameters, only three factors were independently associated with ICU mortality on the multivariate analysis (Table 6) : SOFA score at admission, occurrence of diastolic dysfunction, and need for invasive MV. The results were similar when the age was forced into the model. Survival in ICU was significantly worse in patients presenting diastolic dysfunction (e ′ ≤8 cm s 21 ) with a 71% cumulative incidence of death in ICU vs 21% for patients without diastolic dysfunction (P,0.0001) (Fig. 3) .
Discussion
We report herein on 72 cancer patients admitted to ICU for septic shock over a 30 month period. To our knowledge, this is the largest study evaluating the prognosis of septic myocardial dysfunctions in cancer patients presenting with septic shock. Among echocardiographic parameters, only diastolic dysfunction at the onset of septic shock was independently associated with ICU mortality. Overall, three factors were independently associated with ICU mortality: SOFA score at admission, occurrence of diastolic dysfunction, and need for invasive MV. Interestingly, diastolic dysfunction was not associated with exposure to cardiotoxic drugs.
Cardiac dysfunction and septic shock
Systolic dysfunction is common during sepsis. 21 Its incidence and severity seems to be underestimated by LVEF. Actually, LVEF, which strongly depends on LV after load, may overestimate systolic function during septic shock because of the decrease in systemic resistance. 9 22 Our study confirms that systolic dysfunction is a poor predictor of ICU mortality in septic patients. 8 During septic shock, physicians are still focused on systolic function whereas diastolic dysfunction is largely ignored despite its first description around the 1980s. 7 8 During diastole, LV dilatation can be observed in survivors and highlights the importance of diastolic function in a context of septic shock. 7 23 Elevation of N-terminal pro-brain natriuretic peptide, which could reflect a diastolic dysfunction, 24 is associated with poor prognosis in septic shock, both in the general population 25 and cancer patients. 16 Mitral annular early-diastolic peak velocity (e ′ ) is an index of LV relaxation. Although a recent study 26 suggests that e ′ could be enhanced with an adequate volume resuscitation in septic patients, it is usually considered as a strong load-independent parameter of diastolic dysfunction 11 27 and is known as a major mortality predictor in cardiac diseases. 28 Our study, supported by two recent reports, 24 29 confirms that diastolic dysfunction (e ′ ≤8 cm s 21 ), using e ′ -wave evaluation, is an independent predictor of mortality during septic shock. High E/e ′ ratio, which is closely correlated with LV filling pressure, could reflect a low LV relaxation or compliance. 30 When compared with e ′ , in our study, E/e ′ ratio was not independently associated with prognosis. E/e ′ ratio might not be an accurate outcome predictor since it is not only a marker of the diastolic function but also the result of fluid resuscitation management. Although the amount of fluid resuscitation during septic shock was usually determined using echocardiography and E/e ′ ratio in our ICU, our findings were only based on the first echocardiographic assessment for each patient. In this situation, the echo-guided resuscitation might not affect this first assessment. Interestingly, diastolic LV dysfunction was not associated with vasopressor dose at the time of echocardiography. This suggests that other factors such as septic pro-inflammatory [interleukin (IL-1), IL-6, tumour necrosis factor a] and anti-inflammatory (IL-4, IL-10, transforming growth factor b) cytokines may be associated with diastolic LV dysfunction during sepsis. 21 Although treatments commonly used during diastolic dysfunction seem to be theoretically antagonistic to the management of septic shock, few have been evaluated in this situation. Interestingly, preclinical and clinical studies with b1 receptor blockers during sepsis have shown promising results. 31 32 Monitoring of diastolic function and therapeutic interventions improving cardiac relaxation need to be evaluated in cancer patients presenting septic shock. 26 31 32 RV dilatation during septic shock is common. 9 Although it can be consecutive to a respiratory impairment, MV, or both, a real alteration of RV contractility due to sepsis may occur. 33 Very little data exist concerning its prognostic value, but we have previously shown that RV dysfunction can be associated with ICU mortality in cancer patients. 16 RV systolic dysfunction, as defined by a RV tissue Doppler peak systolic velocity ,12 cm s 21 , is associated with mortality in severe sepsis. 34 Regarding our 'echocardiographic model', RV dilatation was strongly associated with ICU mortality in the univariate analysis but not in the multivariate analysis. When RV dilatation was forced into the 'classical model', RV dilatation appeared to be an independent factor of ICU mortality among RRT, invasive MV, and diastolic dysfunction (data not shown). RV failure could be associated with worse outcomes, which needs to be confirmed by further large studies.
Diastolic dysfunction: age, sepsis, and cardiotoxicity
As Landesberg and colleagues, 29 we found a strong correlation between age and diastolic dysfunction. Contrasting with their results for which non-survivors were older than survivors, our two groups had similar age, strengthening the association between septic cardiac dysfunction and mortality. The analysis of delta e ′ which reflects non-physiological diastolic dysfunction was significantly higher in non-survivors, underlining that diastolic dysfunction, in a context of sepsis, was more severe in non-survivors regardless of the age. Early diastolic dysfunction is associated with ICU mortality Radical change in life expectancy of cancer patients has occurred in the past few decades thanks to new therapeutics; accordingly, drug-induced cardiotoxicity is now an important issue in cancer survivors. 20 Thus, studying cardiac function in cancer patients requires considering the risk of drug-induced cardiotoxicity. Interestingly, in our study, we did not observe any association between history of cardiotoxic anticancer treatments and diastolic dysfunction. A selection of patients more likely to benefit from chemotherapy, intensive care management, or both may explain this trend.
Limitations
Our study has several limitations. This is a single-centre study in which echocardiographic measurements were made only at a single point in time for each patient. Therefore, we were unable to assess stability of these variables. However, all patients were studied within 48 h of developing septic shock and the potential influence of fluid balance on echographic data was meticulously considered. Furthermore, as pre-morbid or follow-up echographic data were not available, we could not demonstrate whether diastolic dysfunction was a pre-existing condition, due to sepsis, or both.
Conclusions
As expected, the magnitude of organ failures is strongly associated with outcome in cancer patients presenting with septic shock. Whereas systolic dysfunction is not associated with prognosis, early diastolic dysfunction is a strong and independent predictor of ICU mortality. The present study shows that exposure to cardiotoxic drugs is not associated with diastolic dysfunction in this setting. In addition to systolic function, a systematic evaluation of diastolic function by cardiologists in the follow-up of cancer patients exposed to cardiotoxic drugs could provide interesting insights. Further studies incorporating monitoring of diastolic function and therapeutic interventions improving cardiac relaxation need to be evaluated in cancer patients presenting with septic shock.
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